Cargando…
Novel HRPT2/CDC73 Gene Mutations and Loss of Expression of Parafibromin in Chinese Patients with Clinically Sporadic Parathyroid Carcinomas
OBJECTIVE: It is widely recognized that the diagnosis of parathyroid carcinoma (PC) is often difficult because of the overlap of characteristics between malignant and benign parathyroid tumors, especially at an early stage. Based on the identification of tumor suppressor gene HRPT2/CDC73 and its ass...
Autores principales: | Wang, Ou, Wang, Chunyan, Nie, Min, Cui, Quancai, Guan, Heng, Jiang, Yan, Li, Mei, Xia, Weibo, Meng, Xunwu, Xing, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447805/ https://www.ncbi.nlm.nih.gov/pubmed/23029104 http://dx.doi.org/10.1371/journal.pone.0045567 |
Ejemplares similares
-
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer
por: Cetani, Filomena, et al.
Publicado: (2013) -
Genome-Wide and Locus Specific Alterations in CDC73/HRPT2-Mutated Parathyroid Tumors
por: Sulaiman, Luqman, et al.
Publicado: (2012) -
Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features
por: Gill, Anthony J., et al.
Publicado: (2019) -
Characterization of a New CDC73 Missense Mutation that Impairs Parafibromin Expression and Nucleolar Localization
por: Masi, Giulia, et al.
Publicado: (2014) -
Diagnostic and prognostic implications of parafibromin immunohistochemistry in parathyroid carcinomaT
por: Pyo, Jung-Soo, et al.
Publicado: (2019)